Newsroom
STAY INFORMED
Recent News
Imricor Commences VISABL-VT Trial
April 16, 2025Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial
August 14, 2024VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
June 21, 2024Imricor Receives Approval from Saudi Food and Drug Authority
January 17, 2024See All News →
Upcoming Events
There are no upcoming events currently.